Novavax Reports First Quarter 2008 Financial Results
EUSA Pharma Completes Acquisition Of Cytogen Corporation
University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
Dendreon Reports First Quarter 2008 Financial Results
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
Insmed Announces First Quarter 2008 Financial Results
Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.